Overview
Ivor Douglas is an Intensive Care Medicine provider in Valhalla, New York. Dr. Douglas is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pneumonia, Acute Respiratory Distress Syndrome (ARDS), COVID-19, Cerebral Hypoxia, and Endoscopy.
His clinical research consists of co-authoring 126 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles and participated in 2 clinical trials in the study of COVID-19.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Woods Rd, Valhalla, NY 10595
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Montefiore Medical Center
Michelle N. Gong, MD, MS, is a Professor of Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. She is also the Chief of Critical Care Medicine, Associate Chief of Academic Affairs, and Director of Critical Care Research at Montefiore. Dr. Gong’s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications. She joined the Einstein/Montefiore faculty in July 2009. Dr. Gong received an Engineering degree at the University of Pennsylvania. She then went on to earn her Doctor of Medicine at the Yale University School of Medicine. She completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. Dr. Gong studied at the Harvard School of Public Health, receiving her Master’s Degree in Clinical Epidemiology. Dr. Gong has spent her career improving outcomes in patients along the entire continuum of critical illness, from its development to progression and recovery, with an overall focus on the prediction and prevention of acute organ failure and its complications. Her current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems. Under her leadership, Montefiore/Einstein was selected as a clinical center for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network which represents the first representation of a medical center from the New York and the tri-state area. Collaborating with the research informatics and healthcare industries, Dr. Gong has fostered the application of informatic approaches to drive improvement in healthcare delivery and research. Dr. Gong is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Severe Acute Respiratory Syndrome (SARS), and Cerebral Hypoxia.
New York-Presbyterian Hospital
Edward Schenck is an Intensive Care Medicine provider in New York, New York. Dr. Schenck is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Severe Acute Respiratory Syndrome (SARS), and Thrombectomy.
Kings Highway Hospital
Samir Farhat is an Intensive Care Medicine provider in Brooklyn, New York. Dr. Farhat is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Asthma in Children, Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Respiratory Distress Syndrome (ARDS)
- Cerebral HypoxiaDr. Douglas isAdvanced. Learn about Cerebral Hypoxia.
- COVID-19Dr. Douglas isAdvanced. Learn about COVID-19.
- PneumoniaDr. Douglas isAdvanced. Learn about Pneumonia.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- Chronic Obstructive Pulmonary Disease (COPD)
- EmpyemaDr. Douglas isExperienced. Learn about Empyema.
- EndoscopyDr. Douglas isExperienced. Learn about Endoscopy.
- Hospital-Acquired PneumoniaDr. Douglas isExperienced. Learn about Hospital-Acquired Pneumonia.
- Lung MetastasesDr. Douglas isExperienced. Learn about Lung Metastases.
- Pleural EffusionDr. Douglas isExperienced. Learn about Pleural Effusion.